ASSETMARK, INC

Position in GRFS — Grifols SA

CIK 1344551 CONCORD, CA

Position in GRFS

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$6,060

+$5,459 QoQ

Shares Held

856

+1041.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#133

of 164 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ASSETMARK, INC holds $468,730,500 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	248,532	$89,998,407
2	LLY	ELI LILLY & Co	65,278	$78,296,398
3	NVS	Novartis AG	442,978	$69,423,512
4	JNJ	Johnson & Johnson	156,545	$39,757,733
5	AZN	Astrazeneca PLC	192,721	$36,543,756
6	MRK	Merck & Co., Inc.	252,444	$32,439,054
7	ABBV	AbbVie Inc.	123,655	$31,116,544
8	GSK	GSK plc	551,436	$28,906,275

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,060	856	+1041.3%	Shares	Sole	2026-07-30
2026-03-31	$601	75	-65.0%	Shares	Sole	2026-05-06
2025-12-31	$2,000	214	-7.0%	Shares	Sole	2026-01-23
2025-09-30	$2,290	230	+7.5%	Shares	Sole	2025-11-06
2025-06-30	$1,934	214	-98.5%	Shares	Sole	2025-08-04
2022-06-30	$171,772	14,459	+31.8%	Shares	Sole	2022-08-03
2021-09-30	$160,271	10,970	+6.8%	Shares	Sole	2021-11-12
2021-06-30	$178,167	10,269	+17.9%	Shares	Sole	2021-08-16
2021-03-31	$150,630	8,712	-1.0%	Shares	Sole	2021-05-14
2020-12-31	$162,308	8,802	+7.1%	Shares	Sole	2021-02-10
2020-09-30	$142,599	8,219	-78.9%	Shares	Sole	2020-11-13
2020-06-30	$711,232	38,993	+29.8%	Shares	Sole	2020-08-11
2020-03-31	$605,227	30,051	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.